# Pathways for Regulatory Innovation and Strategic Modernization (PRISM)

Source: https://welltoldgrants.com/grants/rfa-fd-26-007-pathways-for-regulatory-innovation-and-strategic/  
Official notice: https://www.grants.gov/search-results-detail/361724

> Food and Drug Administration offered grants of up to $1.3 million to the applicants described in the notice. It expected to make one award worth $1.3 million in total. Applications closed on April 30, 2026.

| Field | Value |
|---|---|
| Opportunity number | RFA-FD-26-007 |
| Agency | Food and Drug Administration |
| Status | Forecast |
| Deadline | April 30, 2026 |
| Award ceiling | $1.3 million |
| Award floor | not stated |
| Expected awards | 1 |
| Total funding | $1.3 million |
| Cost sharing | not required |
| Assistance Listings | 93.103 |

## Who can apply

- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Only the following applicant is eligible to apply for this single source funding: Reagan-Udall Foundation for the Food and Drug Administration.

## What the grant funds

The Pathways for Regulatory Innovation and Strategic Modernization (PRISM) cooperative agreement is intended to advance public health by strengthening the scientific, collaborative, and operational foundations needed to modernize regulatory oversight in an increasingly complex and rapidly evolving public health landscape. As innovation in medical products, diagnostics, foods, and digital health accelerates, our nation must continuously adapt its regulatory science approaches to ensure timely access to safe, effective, and high-quality products for the American public. PRISM is designed to support this modernization by enabling forward-looking, non-regulatory collaborations that align with the Commissioner’s strategic priorities and the Administration’s broader public health goals. PRISM provides a flexible, scalable approach to patient, consumer, industry, academia, and healthcare workforce engagement to generate applied scientific knowledge, tools, and approaches that enhance regulatory predictability, efficiency, and transparency. By leveraging independent expertise and real-world insights, PRISM bridges gaps between innovation and regulation to optimize uptake of emerging technologies, evolving consumer needs, and new sources of evidence such as real-world data and real-world evidence.

## Questions people ask

### Is RFA-FD-26-007 still open?

No. It closed on April 30, 2026. A newer notice is open: PAR-27-017, rolling or no fixed deadline.

### Who can apply for Pathways for Regulatory Innovation and Strategic Modernization (PRISM)?

Food and Drug Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Pathways for Regulatory Innovation and Strategic Modernization (PRISM)?

Closed April 30, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $1.3 million each. About $1.3 million in total for one award.

### Who has won Food and Drug Administration Research grants before?

The largest recipients over five fiscal years were The Critical Path Institute, National Environmental Health Association, Association of Food & Drug Officials. The program made 940 awards worth $1.2 billion in that time.